Charles River, Related Sciences team up for AI-driven drug discovery
Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences have announced a multi-program collaboration valued at an undisclosed amount to deploy Logica, an AI-powered drug solution, across several previously undrugged targets. This initiative aims to discover new medicines that address key unmet needs in a variety of disease areas, including cancer immunotherapy, autoimmunity, and […]